Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Syngene International Limited
  6. News
  7. Summary
    539268   INE398R01022

SYNGENE INTERNATIONAL LIMITED

(539268)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Syngene International : Posts Higher Profit in January-March

04/28/2021 | 12:10am EDT


© MT Newswires 2021
All news about SYNGENE INTERNATIONAL LIMITED
10/21SYNGENE INTERNATIONAL : Logs 21% Drop in Consolidated Net Profit in Fiscal Q2; Shares Slid..
MT
10/20Syngene International Limited Reports Earnings Results for the Second Quarter and Six M..
CI
07/20SYNGENE INTERNATIONAL : Consolidated Net Profit Climbs in Fiscal Q1
MT
07/20Syngene International Limited Announces Resignation of John M M Shaw from the Board of ..
CI
07/20Syngene International Limited Reports Earnings Results for the First Quarter Ended June..
CI
06/22Syngene International Limited Appoints Dr. Kush Parmar as an Additional Director (Indep..
CI
05/26DYADIC INTERNATIONAL : Syngene to Join Forces for COVID-19 Vaccine Production
MT
05/26SYNGENE INTERNATIONAL : Dyadic announces development of COVID-19 Vaccine in India
AQ
05/26Dyadic International, Inc. Enters into Collaboration with Syngene International Limited
CI
04/28BIOCON : Syngene targets delivering 500,000 vials of remdesivir in India as COVID-19 surge..
RE
More news
Financials
Sales 2022 26 105 M 348 M 348 M
Net income 2022 4 111 M 54,8 M 54,8 M
Net cash 2022 4 104 M 54,7 M 54,7 M
P/E ratio 2022 56,5x
Yield 2022 0,08%
Capitalization 230 B 3 065 M 3 065 M
EV / Sales 2022 8,65x
EV / Sales 2023 7,41x
Nbr of Employees 5 437
Free-Float 28,5%
Chart SYNGENE INTERNATIONAL LIMITED
Duration : Period :
Syngene International Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SYNGENE INTERNATIONAL LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 579,50 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Jonathan Hunt Chief Executive Officer, MD & Executive Director
Sibaji Biswas Chief Financial Officer
Kiran Mazumdar-Shaw Non-Executive Chairman
Mahesh K Bhalgat Chief Operating Officer
Priyadarshini I. Mahapatra Secretary & Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
SYNGENE INTERNATIONAL LIMITED-9.40%3 065
MODERNA, INC.212.57%131 807
LONZA GROUP AG32.74%61 177
IQVIA HOLDINGS INC.43.38%49 092
SEAGEN INC.-2.12%31 189
CELLTRION, INC.-38.86%25 455